Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-11-03

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Asthma

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Asthma in 3 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busse, WW1
Anderson, CL1
Lagente, V1
Hichami, A1
Boichot, E1
Martins, MA1
Silva, PM1
Khan, MM1
Townley, RG1

Other Studies

3 other studies available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Asthma

ArticleYear
The granulocyte response to the phosphodiesterase inhibitor RO 20-1724 in asthma.
    The Journal of allergy and clinical immunology, 1981, Volume: 67, Issue:1

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Asthma; Cyclic AMP; Dose-Response Relationship, Drug

1981
Asthma and airway inflammation: potential anti-inflammatory activities of phosphodiesterase inhibitors.
    Allergie et immunologie, 1995, Volume: 27, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Airway Resistan

1995
Cytokine studies in allergy and asthma.
    Proceedings of the Western Pharmacology Society, 1994, Volume: 37

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Asthma; Cytokines; Humans; Hypersensitivity

1994